Chemical Compound
Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; Enzalutamide; MDV 3100; Xtandi
CAS Registry Number
915087-33-1
Primary record
Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; Enzalutamide; MDV 3100; Xtandi
- 库存
- 4,737 克
- 纯度
- 98.3 %
- CAS
- 915087-33-1
化合物标识与属性
- CAS
- 915087-33-1
- PubChem CID
- 15951529
- SMILES
- CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C
- Canonical SMILES
- CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F
名称与同义词
- Enzalutamide
- 915087-33-1
- MDV3100
- XTANDI
- Enzalutamide (MDV3100)
- MDV-3100
- Enzalutamida
- MDV 3100
- enzalutamidum
- MDV3100 (Enzalutamide)
- Enzalutamide [USAN]
- 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide
- Xtandi (TN)
- MDV3100 Enzalutamide
- 93T0T9GKNU
- Tube704
- Enzalutamide (Standard)
- Enzalutamide [USAN:INN]
- RefChem:58964
- UNII-93T0T9GKNU
- Enzalutamide Intermediates
- ENZALUTAMIDE [MI]
- Enzalutamide; MDV3100
- C21H16F4N4O2S
- Enzalutamide (JAN/USAN)
- ENZALUTAMIDE [INN]
- ENZALUTAMIDE [JAN]
- D0M1YR
- D0QK5X
- Enzalutamide (AR inhibitor)
- ENZALUTAMIDE [VANDF]
- MFCD14155804
- Enzalutamide (MDV3100)?
- MDV 3100 (Enzalutamide)
- cc-412
- CHEBI:68534
- MLS006010067
- ENZALUTAMIDE [WHO-DD]
- SCHEMBL189749
- DTXSID10912307
- WXCXUHSOUPDCQV-UHFFFAOYSA-N
- GTPL6812
- orb1301219
- CHEMBL1082407
- SCHEMBL29352764
- CTK8B6725
- ASP9785
- EX-A046
- L02BB04
- MDV3101
- QCR-130
- MDV 3100-d3
- BCPP000169
- DTXCID301341329
- ENZALUTAMIDE [ORANGE BOOK]
- GLXC-90012
- HMS3654L07
- HMS3672M13
- HMS3744C19
- HMS5079M21
- NC-54
- AMX10212
- AMY10296
- AOB87731
- ASP-9785
- BCP02361
- THC33182
- MDV3100/MDV-3100
- ABP000459
- ANW-54164
- BBL102957
- BDBM50425732
- EBC-17120
- HY-70002R
- NSC755605
- NSC766085
- s1250
- STL556766
- ZINC34806477
- AKOS015851022
- MDV-3100;Enzalutamide;MDV 3100
- ACN-026804
- BCP9000901
- CCG-264879
- CS-0317
- DB08899
- FC65076
- NSC-755605
- NSC-766085
- RL05765
- SB20413
- KS-0000079W
- NCGC00263120-01
- AC-26924
- AK-72825
- AN-16279
- AS-17047
- BC660065
- BR-72825
- CJ-18592
- HY-70002
- MDV3100, 95%
- SC-69109
- SMR004701227
- AB0008149
- TC-142909
- A3003
- FT-0670957
- NS00040668
- ST24028748
- SW219288-1
- W9480
- J2.922.494C
- A10562
- A25302
- D10218
- S-3847
- 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide
- AB01565849_02
- EN300-20605530
- SR-01000941580
- Q1996756
- SR-01000941580-1
- BRD-K56851771-001-01-9
- BRD-K56851771-001-06-8
- 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide
- 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide
- MDV-3100, 915087-33-1
- B0084-155497
- 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
- 4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide
- Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-
- 1443331-82-5
- 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl)-2-fluoro-N-methylbenzamide
- 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-benzamide
- 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-me
- 805-022-1
- Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-
- Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; Enzalutamide; MDV 3100; Xtandi
- Benzamide,4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-
- N-Methyl-2-fluoro-4-[2-thioxo-3-[3-(trifluoromethyl)-4-cyanophenyl]-4-oxo-5,5-dimethylimidazolidine-1-yl]benzamide
- n-methyl-4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-fluo
- N-Methyl-4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-4-oxo-2-thioxo-5,5-dimethylimidazolidine-1-yl]-2-fluorobenzamide